OBJECTIVES: To obtain national data on demographics, investigation, treatment and short-term outcome for patients admitted with acute heart failure. DESIGN: Retrospective survey of emergency admissions with acute heart failure from October 2005 to March 2006. SETTING: Acute NHS trusts in England, Wales and Northern Ireland. MAIN OUTCOME MEASURES: Patient demographics, referral source, admission characteristics, admission pathway, patient heart failure treatment on admission, length of stay, short-term mortality, discharge heart failure treatment, specialist follow-up and delayed discharge. RESULTS: 176/177 (99%) acute trusts responded and 9387 records were surveyed. Patients mean age was 77 (SD 11) years, 50% were women and 56% had prior history of heart failure. On average, women were 5 years older than men (80 vs 75 years, p<0.001), were less likely to have had echocardiography (52% vs 60%, p<0.001), and if previously diagnosed with heart failure less likely to be treated with ACE inhibitors (58.3% vs 66.8%, p<0.001), beta-blockers (30.1% vs 35.5%, p = 0.033) or aldosterone antagonists (18.9% vs 22.5%, p<0.001) at admission. In-hospital mortality was 15%. Age-adjusted mortality was higher in men (16% vs 14%, p = 0.042). 75% of patients were admitted with moderate to severe symptoms (NYHA class III or IV). Women were less likely to be prescribed anti-failure medication, except diuretics, on discharge (ACE-I/AIIRA 66.5% vs 73.4%, beta-blocker 31.3% vs 37.5%, aldosterone antagonists 23.4% vs 30.1%, all p<0.001). Only 20% of patients had planned specialist heart failure follow-up, with <1% referred for rehabilitation or specialist palliative care. CONCLUSION: Many patients admitted to acute hospitals in England, Wales and Northern Ireland are not being managed fully in accordance with international evidence-based guidelines. In comparison with earlier UK studies, the use of echocardiography and ACE-I and beta-blockers has increased, and length of stay reduced. Only a minority of patients are seen, or followed up, by a specialist service. Women seem to be less well managed against recommended guidelines. Significant and sustained effort is required to address gender inequalities in the provision of heart failure care.
OBJECTIVES: To obtain national data on demographics, investigation, treatment and short-term outcome for patients admitted with acute heart failure. DESIGN: Retrospective survey of emergency admissions with acute heart failure from October 2005 to March 2006. SETTING: Acute NHS trusts in England, Wales and Northern Ireland. MAIN OUTCOME MEASURES: Patient demographics, referral source, admission characteristics, admission pathway, patientheart failure treatment on admission, length of stay, short-term mortality, discharge heart failure treatment, specialist follow-up and delayed discharge. RESULTS: 176/177 (99%) acute trusts responded and 9387 records were surveyed. Patients mean age was 77 (SD 11) years, 50% were women and 56% had prior history of heart failure. On average, women were 5 years older than men (80 vs 75 years, p<0.001), were less likely to have had echocardiography (52% vs 60%, p<0.001), and if previously diagnosed with heart failure less likely to be treated with ACE inhibitors (58.3% vs 66.8%, p<0.001), beta-blockers (30.1% vs 35.5%, p = 0.033) or aldosterone antagonists (18.9% vs 22.5%, p<0.001) at admission. In-hospital mortality was 15%. Age-adjusted mortality was higher in men (16% vs 14%, p = 0.042). 75% of patients were admitted with moderate to severe symptoms (NYHA class III or IV). Women were less likely to be prescribed anti-failure medication, except diuretics, on discharge (ACE-I/AIIRA 66.5% vs 73.4%, beta-blocker 31.3% vs 37.5%, aldosterone antagonists 23.4% vs 30.1%, all p<0.001). Only 20% of patients had planned specialist heart failure follow-up, with <1% referred for rehabilitation or specialist palliative care. CONCLUSION: Many patients admitted to acute hospitals in England, Wales and Northern Ireland are not being managed fully in accordance with international evidence-based guidelines. In comparison with earlier UK studies, the use of echocardiography and ACE-I and beta-blockers has increased, and length of stay reduced. Only a minority of patients are seen, or followed up, by a specialist service. Women seem to be less well managed against recommended guidelines. Significant and sustained effort is required to address gender inequalities in the provision of heart failure care.
Authors: Andrea D Foebel; George A Heckman; John P Hirdes; Suzanne L Tyas; Erin Y Tjam; Robert S McKelvie; Colleen J Maxwell Journal: Drugs Aging Date: 2011-07-01 Impact factor: 3.923
Authors: Sean P Collins; Peter S Pang; Christopher J Lindsell; Demetrios N Kyriacou; Alan B Storrow; Judd E Hollander; J Douglas Kirk; Chadwick D Miller; Richard Nowak; W Frank Peacock; Miguel Tavares; Alexandre Mebazaa; Mihai Gheorghiade Journal: Eur J Heart Fail Date: 2010-08-25 Impact factor: 15.534
Authors: Owais Dar; Jillian Riley; Callum Chapman; Simon W Dubrey; Stephen Morris; Stuart D Rosen; Michael Roughton; Martin R Cowie Journal: Eur J Heart Fail Date: 2009-01-27 Impact factor: 15.534
Authors: Renata R T Castro; Luka Lechnewski; Alan Homero; Denilson Campos de Albuquerque; Luis Eduardo Rohde; Dirceu Almeida; João David; Salvador Rassi; Fernando Bacal; Edimar Bocchi; Lidia Moura Journal: Arq Bras Cardiol Date: 2021-01 Impact factor: 2.000